JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Characteristics of ocular higher-order aberrations in patients with pellucid marginal corneal degeneration.

PURPOSE: To evaluate the characteristics of higher-order aberrations (HOAs) in eyes with pellucid marginal corneal degeneration (PMCD).

SETTING: Department of Ophthalmology, Osaka University Medical School, Osaka, Japan.

METHODS: Ocular HOAs were measured by aberrometry in 20 eyes with PMCD (PMCD group), 76 eyes with keratoconus (KC group), and 105 normal eyes (control group) with a 4.0 mm pupil. The magnitudes and axes of trefoil, coma, tetrafoil, and secondary astigmatism and the magnitude of spherical aberration were compared between the 3 groups using vector analysis of Zernike terms.

RESULTS: The mean axes of coma in the PMCD group (85.5 degrees) and KC group (82.5 degrees) were opposite the axis in the control group (253.7 degrees). The magnitude of coma was significantly lower in the PMCD group (0.27 microm +/- 0.19 [SD]) than in the KC group (0.70 +/- 0.37 microm) (P < .05). The mean axes of trefoil in the PMCD group (27.1 degrees) and control group (35.4 degrees) were opposite the axis in the KC group (93.8 degrees). The magnitude of spherical aberration was significantly higher in the PMCD group (0.086 +/- 0.10 microm) than in the KC group (-0.030 +/- 0.13 microm) (P < .05); the spherical aberration signs were opposite in the groups.

CONCLUSIONS: Although PMCD and KC are categorized as noninflammatory corneal thinning disorders, the HOA patterns in the 2 groups differed, possibly due to differences in the positions of the corneal apex. PMCD and KC may cause distinctively different deterioration in the quality of vision.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app